1. Apers WMJ, De Vries LS, Groenendaal F, et al. Delay in Treatment of Neonatal Seizures: A Retrospective Cohort Study. Neonatology 2021; 117: 599–605.
2. Kienitz R, Kay L, Beuchat I, et al. Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability. CNS Drugs 2022; 36: 951–975.
3. Pavel AM, Rennie JM, de Vries LS, et al. Neonatal Seizure Management: Is the Timing of Treatment Critical? J Pediatr 2022; 243: 61-68.e2.
4. Glykys J, Staley KJ. Diazepam effect during early neonatal development correlates with neuronal Cl-. Ann Clin Transl Neurol 2015; 2: 1055–1070.
5. Momen AA, Azizi Malamiri R, Nikkhah A, Jafari M, Fayezi A, Riahi K, Maraghi E. Efficacy and safety of intramuscular midazolam versus rectal diazepam in controlling status epilepticus in children. Eur J Paediatr Neurol. 2015 Mar;19(2):149-54. doi: 10.1016/j.ejpn.2014.11.007.
6. Gidal B, Detyniecki K. Rescue therapies for seizure clusters: Pharmacology and target of treatments. Epilepsia. 2022 Sep;63 Suppl 1(Suppl 1):S34-S44. doi: 10.1111/epi.17341.
7. Ziobro JM, Eschbach K, Shellhaas RA. Novel Therapeutics for Neonatal Seizures. Neurotherapeutics 2021; 18: 1564–1581.
8. Handryastuti S. Kejang pada Neonatus, Permasalahan dalam Diagnosis dan Tata laksana. Sari Pediatr 2016; 9: 112.
9. Dhaliwal JS, Rosani A, Saadabadi A. Diazepam. StatPearls, 2024. https://www.ncbi.nlm.nih.gov/books/NBK537022/
10. Ruggiero A, Ariano A, Triarico S, et al. Neonatal pharmacology and clinical implications. Drugs Context 2019; 8: 1–9.
11. Ismael S, Soetomenggolo TS, Pusponegoro HD, et al. Rekomendasi penatalaksanaan status epileptikus. Jakarta: Ikatan Dokter Anak Indonesia, 2016.
12. Deliana M. Tata Laksana Kejang Demam pada Anak. Sari Pediatr 2016; 4: 59.
13. IDAI. Rekomendasi Penatalaksanaan Kejang Demam. 2016. https://www.pediatricfkuns.ac.id/data/ebook/rekomendasi-kejang-demam.pdf